NIFTY  8,926.90  0.21%
  SENSEX  28,864.70  0.36%
 CURRENCY  Rs  66.93/$ 70.86/€, 83.36/£
  GOLD  29,218.00  -0.28%
  SILVER  42,708.00  -0.30%
  DAX  11,998.60  0.26%
  FTSE  7,302.25  0.38%
  CAC  4,895.88  0.12%
  HANG SENG  24,202.00  0.99%
  NIKKEI  19,379.90  -0.01%
  Shanghai Composite  3,261.22  0.14%
  DOW JONES  20,743.00  0.58%
  NASDAQ  5,865.95  0.47%
  S&P 500  2,365.38  0.60%
RBI GOVERNOR - Sufficient Flexibility To Move Policy Rate In Either Direction RBI GOVERNOR - Shift In Stance To Help Ensure That Inflation Brought Closer To 4% Aim

Move Towards Cheaper Diabetes Drugs

Video:

Play this video

December 5: India, with at least 60 million diabetes patients, may consider issuing compulsory licences for some patented diabetes management drugs sold in the country. This comes as an effort to make the drugs accessible and affordable. Mint's C.H. Unnikrishnan shares more details on the same.